TEST METHOD ON RENAL DISEASES
    1.
    发明申请
    TEST METHOD ON RENAL DISEASES 审中-公开
    肾脏疾病检测方法

    公开(公告)号:US20120164662A1

    公开(公告)日:2012-06-28

    申请号:US13377510

    申请日:2010-06-09

    IPC分类号: G01N33/566 C07K16/18

    摘要: Provided is a test method for the assessment of the necessity of renal biopsy in a subject to be tested, who is suspected of having a renal disease. Specifically provided are a test method for a renal disease, including using urinary podocalyxin and one or more additional markers in combination, and a test reagent for use in the test method and a test reagent kit for use in the test method. The present invention allows the discrimination of a poor prognosis group even for poor prognosis cases with no overt findings in a conventional test method, and thus allows the assessment of a renal disease, the assessment of the necessity of renal biopsy, prognostic prediction, and the like to be performed exactly.

    摘要翻译: 提供了一种用于评估被检对象的患者肾活检的必要性的测试方法,其被怀疑患有肾脏疾病。 具体提供了肾脏疾病的检测方法,包括使用尿球蛋白胨和一种或多种组合的附加标记物,以及用于测试方法的测试试剂和用于测试方法的测试试剂盒。 本发明允许在常规测试方法中即使对于预后不良的患者进行差异性鉴别,也没有公开的发现,因此可以评估肾脏疾病,评估肾活检的必要性,预后预测和 喜欢被完全执行。

    Use of megalin in urine as marker for detecting renal disorder
    4.
    发明授权
    Use of megalin in urine as marker for detecting renal disorder 有权
    在尿液中使用巨蛋白作为检测肾脏疾病的标记物

    公开(公告)号:US08628930B2

    公开(公告)日:2014-01-14

    申请号:US13266397

    申请日:2010-04-27

    IPC分类号: G01N33/53

    CPC分类号: G01N33/6872 G01N2800/347

    摘要: This invention provides a simple means for detecting a renal disorder, a diagnostic marker for a renal disorder that enables prognostic prediction of a renal disorder (e.g., diabetic nephropathy and IgA nephropathy) and evaluation of the degree of nephropathy at the phase of stage-II diabetic nephropathy by measuring the megalin level in urine associated with a renal disorder used for the detection means, and use of such marker. The invention also provides the use of human megalin obtained from the urine sample of a subject as a marker for detecting a renal disorder.

    摘要翻译: 本发明提供了一种用于检测肾脏疾病的简单方法,一种能够预测肾病(例如,糖尿病性肾病和IgA肾病)的肾病的诊断标志物,并评估II期阶段的肾病程度 通过测量与用于检测手段的肾脏疾病相关的尿液中的巨蛋白水平,以及使用这种标记物,糖尿病性肾病。 本发明还提供了从受试者的尿样获得的人巨蛋白作为检测肾病的标记物的用途。

    USE OF MEGALIN IN URINE AS MARKER FOR DETECTING RENAL DISORDER
    6.
    发明申请
    USE OF MEGALIN IN URINE AS MARKER FOR DETECTING RENAL DISORDER 有权
    使用马替林作为标记用于检测肾功能异常

    公开(公告)号:US20120058489A1

    公开(公告)日:2012-03-08

    申请号:US13266397

    申请日:2010-04-27

    IPC分类号: G01N33/566 G01N21/76

    CPC分类号: G01N33/6872 G01N2800/347

    摘要: This invention provides a simple means for detecting a renal disorder, a diagnostic marker for a renal disorder that enables prognostic prediction of a renal disorder (e.g., diabetic nephropathy and IgA nephropathy) and evaluation of the degree of nephropathy at the phase of stage-II diabetic nephropathy by measuring the megalin level in urine associated with a renal disorder used for the detection means, and use of such marker. The invention also provides the use of human megalin obtained from the urine sample of a subject as a marker for detecting a renal disorder.

    摘要翻译: 本发明提供了一种用于检测肾脏疾病的简单方法,一种能够预测肾病(例如,糖尿病性肾病和IgA肾病)的肾病的诊断标志物,并评估II期阶段的肾病程度 通过测量与用于检测手段的肾脏疾病相关的尿液中的巨蛋白水平,以及使用这种标记物,糖尿病性肾病。 本发明还提供了从受试者的尿样获得的人巨蛋白作为检测肾病的标记物的用途。